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Abstract 
 
Cellular and molecular exercise physiology is the study of the underlying regulatory mechanisms that underpin physiological 
adaptation to exercise. In this historical perspective, I explain how the field emerged following advancements in technology within 
the molecular biology field in general and as a result of some exciting forward thinking by the leading exercise biochemists of the 
time. I also discuss the important advancements in elucidating the mechanisms underlying physiological adaptation to exercise 
using genetic knockout, overexpression and compensatory hypertrophy models in animals, that subsequently enabled the 
translation and future study of key mechanisms that underpin human exercise adaptation. This historical perspective also helps 
decipher the important studies that pioneered the investigation of the cellular signaling networks controlling gene expression in 
response to acute and chronic exercise, the role of satellite cells in repair of skeletal muscle after exercise and finally how the 
important topic of exercise genetics/genomics emerged within the cellular and molecular exercise physiology field. Finally, the 
manuscript identifies that the integration of epigenetics and proteomics to compliment current genome-wide approaches (profiling of 
heritable genetic variants and gene expression) are likely to play an important role in uncovering the cellular and molecular 
regulation of exercise adaptation into the next generation. 
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Introduction 
 
Cellular and molecular exercise physiology is the study of the 
regulatory molecular mechanisms that lead to physiological 
adaptation following exercise. The field is focused particularly at 
the level of the molecule/cell and investigates how the 
microscopic responses to exercise ultimately lead to adaptation 
at the whole tissue and systems level. Broadly, three common 
themes have emerged within this field and include: 1) How the 
environmental ‘stressor’ of exercise modulates the abundance 
and activity of extra- and intra-cellular signaling networks, 
leading to the turning on/off of genes (e.g. mRNA levels) and 
their proteins and culminating in phenotypic changes at the 
cellular or tissue level. 2) The role of heritable genetic traits and 
their associated influence on the physiological response to 
exercise, and; 3) The role of the satellite cells in the repair and 
regeneration of muscle after exercise induced damage. The 
majority of these regulatory mechanisms are studied in blood 
and skeletal muscle tissue and/or isolated satellite cells and 
sometimes adipose tissue, albeit to a lesser extent than muscle 
tissue. This is due to the relative ease of sampling of blood and 
the ever-increasing availability of skeletal muscle biopsy 
sampling in human participants and/or patients. Therefore, this 
editorial provides a historical perspective of the major research 
that has contributed to the emergence of cellular and molecular 
physiology as a field, with a particular focus on the discovery of 
mechanisms that lead to skeletal muscle adaptation.  
 
History of exercise biochemistry and origins of cellular and 
molecular exercise physiology 
 
The first use of human skeletal muscle biopsy techniques to 
study exercise adaptation in humans at the biochemical level 
was by Bergstrom in 1962, publishing the paper ‘Electrolytes in 
Man’ (Bergström, 1962). In 1966 Bergstrom and Hultman were 
the first to measure glycogen synthesis from human muscle 
after exercise to exhaustion (Ahlborg et al., 1967; Bergström 
and Hultman, 1966). Bergstrom and Saltin in 1967 also 
assessed muscle glycogen in the quadriceps of both trained and 
untrained males and after different starting nutritional 
backgrounds (e.g. high carbohydrate/high protein) (Bergström et 
al., 1967; Hermansen et al., 1967). This work was followed by 
Costill in 1971, who extended biopsy measurements for muscle 
glycogen to the gastrocnemius and soleus (as well as 
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quadriceps) after exhaustive running and following multiple 
bouts of exercise (Costill et al., 1971a; Costill et al., 1971b). 
Exercise biochemistry was therefore the first discipline 
attempting to understand some of the changes to biochemical 
parameters following acute and repeated exercise. In this era, 
exercise biochemistry was primarily the study of metabolites 
and protein activity using, exciting novel methodologies that are 
now taken for granted, such as; enzyme based assays, 
spectrophotometric and flourometric analyses together with 
histological measurements. However, even prior to this work in 
human muscle, Gollnick’s seminal work in 1961 applied 
exercise biochemistry in rodent model systems to investigate 
the regulation of ATP and LDH activity in heart and skeletal 
muscle tissue following exercise (Gollnick and Hearn, 1961; 
Hearn and Gollnick, 1961). Holloszy also pioneered the early 
exercise biochemistry field by looking at biochemical enzyme 
activity associated with mitochondrial adaption to aerobic 
exercise in rats (Holloszy, 1967). Booth together with Hollozsy 
(Baldwin et al., 1975; Booth and Holloszy, 1977; Holloszy and 
Booth, 1976) extended this earlier work in more detail over the 
ensuing decade, studying in detail the biochemical adaptation to 
exercise (Booth, 1978; Krieger et al., 1980; Morrison et al., 
1989; Tucker et al., 1981). Pertinent examples came from 
Watson, Stein and Booth who undertook the first work into 
changes at the gene (mRNA) expression (predating polymerase 
chain reaction methods) investigating alpha-actin mRNA after 
muscle immobilization using dot-blot hybridization of radioactive 
p32- labelled plasmids containing the alpha actin cDNA on 
nitrocellulose membranes (Watson et al., 1984). They 
subsequently went on to investigate alpha-actin and cytochrome 
C mRNA expression following both exercise and immobilization 
in rats (Booth et al., 1987; Booth and Watson, 1985; Morrison et 
al., 1989; Morrison et al., 1987). Frank Booth also undertook 
some of the first work on muscle protein synthesis (Booth and 
Seider, 1979) and degradation (Seider et al., 1980) later 
combining these with adaptation at the biochemical and gene 
expression level (Wong and Booth, 1990a; Wong and Booth, 
1990b). It was here that early exercise biochemists laid the 
basis for a field that would soon emerge, leading Booth to his 
postulation within the literature of a specific field called ‘cellular 
and molecular exercise physiology’ (Babij and Booth, 1988; 
Booth, 1988; Booth, 1989; Booth and Thomason, 1991). With 
the advent of polymerase chain reaction (PCR) to amplify RNA 
and DNA templates by Mullis in the late 1980’s (leading to the 
Nobel prize in chemistry in 1993), this made gene expression 
analysis more sensitive, rapid, accurate and enabled higher 
throughput within the molecular biology field (Mullis and 
Faloona, 1987; Saiki et al., 1985). Importantly, Booth’s lab was 
also one of the first to simultaneously undertake direct gene 
transfer into the skeletal muscle of live rodents (Thomason and 
Booth, 1990; Wolff et al., 1990), altering the gene expression of 
candidate genes enabling a powerful model to mechanistically 
ratify (or even refute) the role of specific genes in exercise 
adaptation. Gene knock-down and overexpression models are 
discussed below in this editorial.  
 
Non-human mammalian models of exercise adaptation kick 
started our understanding in humans  
 
The majority of work within cellular and molecular exercise 
physiology in humans is undertaken in skeletal muscle tissue 
due to the routine use of human skeletal muscle biopsies. 
However, non-human mammalian models, predominantly using 
rodents, have paved the way and continue to provide key 
mechanistic insights to understand molecular adaption to 
exercise via the use of gene knock out (KO) and transgenic 
(overexpression) models that are unavailable in human studies 
due to ethical reasons. This type of Nobel prize winning work 
has been available since the 1980s following original pioneering 
work by Capecchi, Evans and Smithies for the introduction of 
customised genetic mutations in rodents (Doetschman et al., 
1987; Evans and Kaufman, 1981; Martin, 1981; Robertson et 
al., 1986; Thomas and Capecchi, 1987). A pertinent example for 
the use of this technology includes work into the metabolic 
regulator, PGC1-, now probably the most common 
gene/protein to be investigated in skeletal muscle adaptation 
following aerobic exercise. Using gene knock out technology, 
following aerobic exercise or cold water therapy, PGC1- was 
confirmed as fundamental in the promotion of mitochondrial 
biogenesis enabling increases in oxidative metabolism in rodent 
models (Lin et al., 2002). Later it was also shown that exercise 
performance was impaired following PGC1- KO (Handschin et 
al., 2007). Furthermore, in terms of muscle mass regulation, the 
double muscling phenotype with a naturally occurring myostatin 
mutation in cattle (McPherron and Lee, 1997), was confirmed 
using myostatin KO mice (McPherron et al., 1997). PGC1- and 
myostatin are discussed in more detail in the section below 
entitled: ‘Exercise induced signal transduction networks.’ Other 
models in rodents that are not possible in humans, but have led 
to large forward strides in understanding the molecular 
regulation of muscle growth, include, synergistic ablation (also 
termed compensatory hypertrophy), which after removal of 
agonist muscles culminates in rapid muscle hypertrophy and 
serves as a model to investigate the molecular regulation of 
muscle growth. This method, was first used by Goldberg in 
1967, who demonstrated a rapid hypertrophic response even 
after only 24 hr after synergistic ablation (Goldberg, 1967).  
 
Exercise induced signal transduction networks 
 
Following exercise and muscle contraction, extracellular 
molecules such as calcium, adrenaline, ephinephrine, growth 
hormone or even mechanical load are rapidly ‘sensed’ by 
skeletal muscle, for example via; ion channels, receptors or 
matrix proteins such as integrins. This leads to intracellular 
signal transduction or signaling cascades that are typically 
activated/inactivated by phosphorylation/dephosphorylation 
respectively, ultimately leading to altered gene expression and 
protein abundance, required for functional adaptation at the 
cellular level. In 1992 the discovery of protein phosphorylation 
by Fischer and Krebs culminated in the award of the Nobel prize 
in chemistry. With this discovery, earlier work in gene 
expression, and the development of Western blotting using 
phosphorylation specific antibodies, enabled the role of protein 
phosphorylation/activity after exercise to be determined 
(Yamaguchi et al., 1985). Below are some of the most important 
discoveries for the cellular signaling networks controlling 
adaptation to exercise in skeletal muscle.  
 
AMPK/PGC1- in endurance exercise adaptation 
 
In 1996, work by Hardie described that activity of an important 
protein, AMP kinase (AMPK) was elevated in response to 
endurance exercise (Winder and Hardie, 1996). Later work by 
Hardie’s group consolidated this observation and revealed that 
this protein was a key component in energy sensing within 
skeletal muscle in response to exercise. Spiegelman’s team 
subsequently identified the transcriptional co-factor PGC-1 as 
the first major regulator of skeletal muscle mitochondrial 
biogenesis (Puigserver et al., 1998; Wu et al., 1999) which was 
later shown to be regulated by AMPK and enable subsequent 
mitochondrial biogenesis (Lin et al., 2002; Puigserver et al., 
1998). PGC-1α is a co-transcriptional regulator and activates a 
group of transcription factors, including nuclear respiratory 
factor 1 (NRF1) and nuclear respiratory factor 2 (NRF2), which 
activate mitochondrial transcription factor A (mtTFA) leading to 
initiation of the replication and transcription of mitochondrial 
DNA, and ultimately mitochondrial biogenesis (Scarpulla, 1997; 
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Virbasius and Scarpulla, 1994). It was later observed that AMPK 
and p38 MAPK directly phosphorylate PGC-1α (Knutti et al., 
2001) and activation of AMPK was also shown to increase the 
gene expression of PGC-1α (Suwa et al., 2003). At around the 
same time, Baar and Hollozy were the first to show that an 
acute bout of swimming increased PGC-1α protein expression 
and NRF-1 binding to the δ-aminolevulinate synthase (δ-ALAS) 
gene promoter and NRF-2 binding to the cytochrome c-oxidase 
IV promoter (Baar et al., 2002). It was later confirmed that 
exercise performance was impaired following PGC1- knock out 
(Handschin et al., 2007). Following this work, it was 
subsequently observed that a reduction in PGC-1α acetylation 
(therefore deacetylation) occurs via AMPK activation of the 
deacetylase, SIRT1 (Cantó et al., 2009). Where SIRT1 
deacetylation of PGC-1α regulates expression of key glucose 
and lipid metabolism genes (Nemoto et al., 2005). However, 
during endurance exercise it was suggested that AMPK 
activation of SIRT1 may not be the main mediator of PGC-1α 
deacetylation, as exercise performance or mitochondrial 
biogenesis was not impaired under SIRT1 KO conditions. 
However, exercise induced PGC-1α deacetylation was thought 
to be instead mediated via a reduction in the acetyltransferase 
GCN5, that would function to reduce acetylation of PGC-1α 
(thereby causing deacetylation) (Philp et al., 2011). Overall 
however, it is now well established that AMPK is one of the 
main regulators of PGC-1α and exercise induced mitochondrial 
biogenesis. 
 
mTOR in load induced muscle mass regulation 
 
With respect to signals promoting muscle growth, in the late 
90’s work by Baar and Esser identified that a major intracellular 
signaling molecule controlling protein synthesis, mammalian 
target of rapamycin (mTOR), was indirectly thought to be load or 
‘mechano’ sensitive (via assessment of downstream translation 
initiator p70s6K). This was observed in rodents following 
electrical stimulation-evoked contractions (100 Hz) of the triceps 
surae. This stimulation resulted in a shortening contraction of 
the plantar flexors and lengthening contractions of the 
dorsiflexors in single bout session of 6 repetitions that lasted 3 
seconds per contraction, with 10 seconds rest between 
repetitions and 50 seconds rest after every 6 repetitions (Baar 
and Esser, 1999). The rodents completed a total of 10 sets 
resulting in 60 repetitions over a 22 minute period in an attempt 
to mimic an single bout of resistance exercise in humans (Baar 
and Esser, 1999). Importantly, the magnitude of muscle mass 
increase following 2 sessions per week over 6 weeks of training 
correlated highly (r > 0.9) with the increases in p70s6k activity 
post 6 hrs acute exercise. Shortly after, Bodine’s group 
observed that load induced muscle growth could be prevented 
using the mTOR inhibitor, rapamycin in rodents (Bodine et al., 
2001). Eight years later, it was confirmed in human skeletal 
muscle that mTOR was a fundamental activated signalling 
molecule following exposure to physiological load (resistance 
exercise), where 12 mg of rapamycin was administered to 
subject prior to performing 11 sets of 10 repetitions of leg 
extension at 70% of the participants 1 repetition maximum. The 
rapamycin group did not show the increase in muscle protein 
synthesis normally seen following resistance exercise 
(Drummond et al., 2009), consolidating its role in resistance 
exercise induced muscle growth. In a murine experiment that 
further consolidated mTORs role in load induced growth, mTOR 
was mutated so that it was no longer sensitive to inhibition via 
rapamycin. In these mice, synergistic ablation led to a similar 
increase in muscle mass as the control group (approx. 42%) 
and rapamycin was unable to prevent load induced growth in 
the experimental mice. Indeed, rapamycin was only effective in 
blocking hypertrophy in the control mice without the mutated, 
rapamycin insensitive mTOR (Goodman et al., 2011). mTOR is 
therefore now considered one of the major regulators of load 
induced skeletal muscle growth. Despite this, it is notoriously 
difficult to measure mTOR via western blotting due to its large 
protein size. Therefore, the majority of studies in human 
molecular exercise physiology tend to measure phosphorylation 
of downstream translation initiator, p70s6K and the activity of 
the protein that is required for translation elongation, 4E-BP1, 
whereby mTOR activates 4E-BP1, after which 4E-BP1 detaches 
from eIF4E, and translation elongation can occur in the 
ribosome and a peptide chain is synthesised on the basis of the 
mRNA blueprint.  
 
Myostatin/Smad signaling as a negative regulator of muscle 
mass  
 
In parallel to mTOR, the myostatin-smad pathway emerged in 
the late 1990s as an important pathway in cellular and 
molecular exercise physiology. It was first established that cattle 
displayed a ‘double muscling’ phenotype if they possessed a 
natural myostatin mutation (McPherron and Lee, 1997). 
Furthermore, with the combination of Folistatin related gene 
(FLRG), an inhibitor of myostatin, muscle mass was quadrupled 
(Lee, 2007). Myostatin, also known as growth differentiation 
factor 8 (GDF-8) and a member of the transforming growth 
factor (TGF) β superfamily of proteins, was identified as a ligand 
that binds to activin receptors (Lee and McPherron, 2001). 
Shortly after the initial discovery that identified myostatin as a 
potent negative regulator of muscle mass, myostatin induced 
intracellular signalling was determined. This was demonstrated 
in experiments showing that suppression of Smad 
transcriptional activity (using transcriptional repressor SKI) 
evoked an approximate 2-fold increase in muscle mass (Sutrave 
et al., 1990), confirming the role for the myostatin ligand in the 
binding to activin receptors that subsequently controlled the 
activity of the downstream Smad proteins. Despite this, at 
present is it unclear whether myostatin is important for exercise 
adaption and/or if it is important to try to manipulate its 
expression with different types/modes/intensities of exercise 
regime. This is because, myostatin knockout mice possess an 
increase in maximal tetanic muscle force but the specific force 
(also termed muscle quality/force relative to the cross-sectional 
area of the muscle) is lower. Suggesting that reductions in 
myostatin may produce more muscle, yet at the expense of 
functional performance (Mendias et al., 2006). The role for 
myostatin in exercise adaptation is further confused after 
evidence has suggested that although myostatin gene 
expression is reduced following resistance exercise, this 
reduction has also been observed after endurance exercise 
where muscle mass is not considerably affected. Others have 
also observed this decrease at the gene and protein level but 
this effect was also shown not to be related to training induced 
changes in muscle mass (Hulmi et al., 2009; Kim et al., 2007). 
Conversely, myostatin has been observed to increase at the 
mRNA level after chronic resistance exercise (Willoughby, 
2004). Interestingly, however, it is perhaps more likely that 
changes in myostatin could also be involved in inhibiting protein 
synthesis via Akt/mTOR/p70S6k pathways and therefore have 
an important role in exercise induced adaption in skeletal 
muscle. Indeed, increases in myostatin administered to skeletal 
muscle cells in-vitro have been shown to reduce the 
phosphorylation of Akt and p70s6K by 50% upstream and 
downstream of mTOR respectively (Trendelenburg et al., 2009). 
Also, Smad2 or Smad3 knockdown (via small interference 
RNA’s/siRNA) has been observed to restore Akt activation in 
the presence of myostatin, suggesting that Smad2 or Smad3 
regulate Akt activity, upstream of mTOR/p70s6k. An in-vivo 
study by Sartori et al. (2009) published simultaneously with that 
of Trendelenburg et al. (2009) showed that activation of the 
Smad2 and Smad3 pathway induced myofibre atrophy, and that 
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this effect could be reversed using small hairpin RNAs 
(shRNAs) blocking Smad2 and Smad3 (Sartori et al., 2009). 
Importantly in this study, constitutive overexpression of Akt also 
prevented muscle fibre atrophy induced by Smad2 or Smad3 
activation. Myostatin has also been shown to increase FOXO 
signalling that functions to block Akt (McFarlane et al., 2006), 
and increase protein degradation via control of ubiquitin ligases 
MuRF1 and MAFbx (Cong et al., 2011; Sartori et al., 2009). 
Finally, in an impressive set of experiments by Baar’s group 
using the same electrical stimulation regime used in the original 
studies to identify mTOR/p70s6K as load-dependent signalling, 
discussed above (Baar and Esser, 1999). It was demonstrated 
that reductions in myostatin following exercise were responsible 
for an 82% increase transcriptional activity of a gene called 
Mighty, that also correlated with muscle growth. The authors 
suggested, that this was not due to the reduction in myostatin 
per se, rather an increase in Notch, a known inhibitor of TGFβ 
(one of the main members of the TGF superfamily that 
myostatin belongs to). Impressively, to confirm this mechanism 
the group used electroporation of Notch (method for muscle 
tissue specific gene overexpression) and this was shown to 
reduce myostatin transcriptional activity and increase Mighty 
gene expression (MacKenzie et al., 2013). Therefore, the TGF 
family members such as myostatin and their associated 
signalling and transcriptional targets do seem to be important in 
adaptation to resistance exercise.   
 
Ca+/Calcineurin/NFAT signaling in fibre type specification 
following exercise 
 
In the late 90’s Chin within the group of Williams paved the way 
for understanding regulators of calcium release from the 
sarcoplasmic reticulum, following muscle contraction and the 
subsequent regulation of the calcium-camodulin-calcineurin 
pathway and its control of the transcription factor NFAT that 
regulated the switching on and off of ‘slow’ / ‘fast’ muscle fibre 
genes (Chin et al., 1998). They used both gene overexpression 
of calcineurinin in-vitro that evoked the expression of slow 
troponin and myoglobin genes and pharmacological inhibitors of 
calcineurin, cyclosporine A in-vivo, that increased the number of 
fast type-II fibres by 50%. Taken together, they suggested that 
there was a fundamental mechanism whereby increases in 
calcineurin promoted slow fibre formation and that inhibition 
promoted fast fibre formation. This was later confirmed in KO 
mice in 2000 (Naya et al., 2000). In the same year it was then 
also determined that the upstream MAPK (ERK) pathway was 
important in this fibre type transition by work of the Schiaffino 
group (Murgia et al., 2000).  
 
Gene expression microarray analysis  
 
Following exercise and signal transduction, transcription factors 
are activated/inactivated and lead to an increase/decrease in 
gene expression (mRNA) via binding to the promoter regions on 
the DNA of target genes. The technological and methodological 
advancements in the assessment of RNA and DNA particularly 
in the late 70s and early 80s with the use of pulsed-field gel 
electrophoresis (Schwartz and Cantor, 1984), early sequencing 
(Anderson, 1981; Beck and Pohl, 1984; Maxam and Gilbert, 
1977; Sanger et al., 1977; Smith et al., 1986), restriction 
fragment-length polymorphisms (Saiki et al., 1985), polymerase 
chain reaction (Mullis and Faloona, 1987; Saiki et al., 1985) and 
the use of bacterial and yeast artificial chromosomes to enable 
‘chromosome walking’ (Hsiao and Carbon, 1979; O'Connor et 
al., 1989) enabled early progress into DNA and gene 
sequencing. Subsequently, the first human genome linkage map 
was produced in 1987 (Donis-Keller et al., 1987) and significant 
advances in fully automated DNA sequencing (Adams et al., 
1991; Prober et al., 1987) allowed the yeast genome to be 
sequenced in 1994 (Feldmann et al., 1994), c. elegans in 1998 
(1998), with the draft of the human genome in Feb 2001 (Lander 
et al., 2001) using whole genome shotgun sequencing (Weber 
and Myers, 1997). Following this, the mouse genome was 
sequenced in 2002 (Waterston et al., 2002) and finally in 2003 
the fully completed human genome (Human Genome 
Sequencing, 2004; Venter et al., 2001) with the rat genome also 
completed shortly after (Gibbs et al., 2004). These advances 
importantly revealed 26,588 protein-encoding gene transcripts 
in the human genome meaning scientists could begin work on 
what regulated these genes in response to human adaptation 
(Human Genome Sequencing, 2004; Venter et al., 2001). In the 
early 2000’s, Booth’s lab in collaboration with Hoffman were the 
first use more extensive genome/transcriptome wide gene 
expression techniques via the use of gene expression 
microarrays. At that time ‘genome-wide’ for this technology 
meant the coverage of around 3000-4000 gene transcripts, as 
well as around 3,000 expressed sequence tags (ESTs) as the 
method just predated the full publication of the human and 
mouse genome sequences and the technology for these arrays 
were in their relatively early stages. In this study they compared 
the gene expression profile of approximately 3000 genes and 
3000 EST’s in both the fast twitch vastus lateralis and the mixed 
soleus muscles (Campbell et al., 2001). They demonstrated that 
there were 59 differentially regulated genes between the two 
muscle fibre types. A year later in 2002, Esser’s group 
undertook the first work into the transcriptome following muscle 
contraction. Electrical stimulation protocols in rodents were 
conducted in regimes that mimicked resistance exercise [as 
discussed previously above (Baar and Esser, 1999; MacKenzie 
et al., 2013)], with corresponding gene microarrays being 
performed. These arrays (Affymetrix Rat U34A GeneChips) 
included around 7000 genes and 1000 ESTs. Importantly, a 
small subset of 18 genes were identified that were expressed 1 
hr after exercise and around 70 genes after 6 hours of exercise  
(Chen et al., 2002). Also, in 2002, 9 weeks of resistance 
exercise in humans was undertaken and skeletal muscle 
biopsies obtained and profiled for around 4000 genes, from 
otherwise sedentary young males and females as well as older 
men and women (5 in each group). Almost 100 genes were 
significantly differentially expressed across all groups in 
response to chronic resistance exercise. Interestingly, there 
were a large number of genes that demonstrated stark 
regulation in male versus female as well as between young 
adult and elderly (Roth et al., 2002). With gene array technology 
rapidly advancing, research by Chen et al., (2003) profiled over 
12,000 gene transcripts following an acute bout of resistance 
exercise in males (albeit only 3 individuals) (Chen et al., 2003). 
Each individual performed 300 concentric contractions with one 
leg and 300 eccentric contractions with the other. In this study 
50% of the genes identified were also identified in their earlier 
rodent studies following electrical stimulation, discussed above 
(Chen et al., 2002). They also identified 6 gene transcripts that 
were related specifically to eccentric muscle contractions. Due 
to the full mouse genome sequencing in 2002 (Waterston et al., 
2002) and finally in 2003 the fully completed human genome 
(Human Genome Sequencing, 2004; Venter et al., 2001) and rat 
genome shortly after (Gibbs et al., 2004), and with the 
knowledge of the 26,588 protein-encoding gene transcripts in 
the human genome, it was soon possible to undertake gene 
arrays for more than 23,000 gene transcripts. A study in 2007 
performed llumina microarrays, and out of 23,000 genes 
identified nearly 600 genes that were differentially regulated in 
the basal state in elderly versus young adult skeletal muscle. 
Interestingly, after 6 months of resistance exercise in young 
versus elderly adults (men and women), resistance exercise 
enabled the return of gene expression for the majority of these 
genes back towards levels observed in the young adult group 
(Melov et al., 2007). In 2007 the first rat transcriptome was 
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profiled following an acute bout of aerobic exercise and 
suggested that 52 genes were differentially expressed post 1 hr 
of exercise (McKenzie and Goldfarb, 2007). In 2011 Timmons 
and Bouchard, using gene microarrays showed that V̇O2max 
responses to chronic endurance training could be predicted by a 
29-gene expression signature or ‘training-responsive 
transcriptome’ using baseline/pre-exercise skeletal muscle 
biopsies. With current microarrays, it is now possible to 
investigate over 47,000 transcripts (i.e. known protein coding 
transcripts but also their variants). In 2012 using these powerful 
arrays an investigation found that 661 genes were affected by 
both an acute bout and chronic (12 weeks resistance training) 
exercise in young and elderly women and correlated with gains 
in muscle size and strength. Interestingly, the most pronounced 
changes in gene expression occurred in fast-twitch (MHC IIa) 
muscle fibres (Raue et al., 2012). These studies have laid the 
foundation for investigating in more detail the specific genes 
important in exercise adaptation, as without such powerful types 
of analysis these genes may never have been identified using a 
candidate, one-gene at a time approach. 
 
Exercise Genetics/ Genomics 
 
As well as work on the turning on/off of genes following 
exercise, molecular exercise physiologists were also interested 
in how genetic inheritance affected exercise performance and 
adaptation. Research led by Claude Bouchard in the 1980’s first 
identified that aerobic capacity and aspects of physical fitness 
could be attributed in part by genetic inheritance (Bouchard et 
al., 1986; Bouchard et al., 1984; Perusse et al., 1987). 
Bouchard began to genotype humans within field of sport and 
exercise science in 1989 (Bouchard et al., 1989). Soon after this 
both mitochondrial and nuclear DNA sequence variants were 
studied (Deriaz et al., 1994; Dionne et al., 1991). Bouchard, 
together with Malina and Pérusse, wrote the first and widely 
appreciated textbook within the sport and exercise genetics field 
entitled: Genetics of Fitness and Physical Performance 
(Bouchard et al., 1997). The book was a fundamental tool for 
academics, scientists and students within sport and exercise 
science as its content covered both classical and novel 
molecular genetics theories relevant to exercise scientists. In 
1998, Montgomery in a paper in Nature reported that the ‘I’ 
polymorphism of the human ACE gene was associated with 
increased duration of repetitive biceps flexion after a program of 
general physical training. This I allele was also increased in 
frequency within a population of elite mountaineers 
(Montgomery et al., 1998). His team later showed that an 
increased frequency of the I allele was observed in elite 5000 
metre British runners versus both 200 and 400-3000 metre 
runners, suggesting an important role for this particular 
genotype in endurance performance. In 2000 Williams, in a 
study led by Montgomery, reported again in the journal Nature, 
that the presence of this ACE allele also conferred an enhanced 
mechanical efficiency in trained muscle (Williams et al., 2000). 
After these initial studies in the early 2000s, and the final 
version of the human genome reported in 2003 that identified 
the location of 2.1 million mutations (single nucleotide 
polymorphisms) (Human Genome Sequencing, 2004; Lander et 
al., 2001; Venter et al., 2001), there was exponential growth in 
the uncovering of genetic polymorphisms associated with sport 
performance, where in 2005 there were only 8 polymorphisms 
associated with sport performance, yet by 2015 there was a 
staggering 155 polymorphisms identified (93 endurance-related 
and 62 power/strength-related genetic markers) (Ahmetov et al., 
2016b). To date there are just under 160 genetic markers that 
are linked to elite athlete status (reviewed in (Ahmetov et al., 
2016a; Ahmetov and Fedotovskaya, 2012). However, 
approximately 80% of the studies have not yet been replicated 
in independent samples (Ahmetov et al., 2016a; Ahmetov and 
Fedotovskaya, 2012). For example, only 31 genetic markers 
have shown positive associations with athlete status in at least 2 
studies and only 12 genotypes in 3 or more studies (Ahmetov et 
al., 2016a). Therefore, despite an increase in the number of 
potential genetic associations with performance, studies seem 
to focus on popular associations such as ACE and ACTN3, due 
to different alleles within these genes being associated with 
somewhat classically opposing physiological traits such as 
endurance versus strength/power performance. Also, out of the 
approximate 160 genetic markers found to date, 29 of them 
have not been replicated by at least 1 other study, therefore 
previous authors have suggested that perhaps some of the 
findings may lack reproducibility or are potentially false positives 
(Ahmetov et al., 2016a). It is also worth noting that the different 
geographical populations included in these studies may further 
increase genetic variability. Also, because single genes are 
unlikely to influence adaptation to exercise, or the physiological 
variation observed in the multi-faceted traits that are required for 
human performance, it is generally accepted that hundreds or 
perhaps even thousands of individuals are required to enable 
candidate gene studies to have adequate statistical power. 
Indeed, in 1998, Claude Bouchard identified that genetic 
heritability accounted for 47% of VO2max/maximal oxygen 
uptake, an important predictor of maximal aerobic capacity and 
endurance performance. This was based on the observation 
that there was 2.5 times more variation in VO2max between 
families than within families (Bouchard et al., 1999; Bouchard et 
al., 1998), suggesting that aerobic capacity has a significant 
genetic component. With the development of high-throughput 
Single Nucleotide Polymorphism (SNP) genotyping methods, 
the human genome sequence and an ethnic group inventory of 
DNA sequence variants (from the HapMap and the 1000 
Genomes projects), the first Genome-wide-association-studies 
(GWAS) were conducted in 2005 (Klein et al., 2005). Fours year 
later in 2009 the first GWAS was conducted that looked at 1.6 
million SNPs associated with physical activity levels in 2622 
non-related individuals. Despite the strongest association with 
physical activity levels identified on chromosome 10q23.2 at the 
3′-phosphoadenosine 5′-phosphosulfate synthase 2 (PAPSS2) 
gene, there were no SNPs that actually achieved significance at 
the genome wide level (De Moor et al., 2009). Bouchard 
together with Timmons (Bouchard et al., 2011; Timmons et al., 
2010) were then the first to really progress the knowledge in this 
area. In their studies, DNA sequence microarrays were used to 
search for a wide range of known polymorphisms that could 
explain variations in endurance performance and trainability. In 
2010, they also combined DNA microarrays to identify a large 
number of known common variants with skeletal muscle gene 
expression arrays to identify genes associated with the VO2max 
training response (gene expression arrays are discussed 
above). The investigation identified 11 single nucleotide 
polymorphisms (SNPs) that explained the variance for 
increased VO2max in response to training. Interestingly, 7 of the 
SNPs were located on transcripts identified in gene expression 
predictor set suggesting a link between DNA variance and gene 
expression in response to increases in aerobic capacity 
following exercise training. In the Bouchard study in 2011, they 
investigated 324,611 single-nucleotide polymorphisms (SNPs) 
to identify variants associated with improvements in VO2max 
following 20 weeks of supervised endurance training. 21 SNPs 
accounted for 49% of the variance of gains in VO2max following 
training, which was very close to the maximal heritability 
estimate of 47% reported previously in the HERITAGE Family 
study described above (Bouchard et al., 1999). Interestingly, it 
was identified in these studies that if the participants possessed 
less than or equal to 9 of these SNPs they were able to improve 
their aerobic capacity by 221 ml/min over the 20 weeks of 
training. Furthermore, if the participant possessed greater or 
equal to 19 of these SNPs they improved on average, a 
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staggering 604 ml/min (Bouchard et al., 2011). These studies 
therefore were the first to identify some of the most important 
genetic variations associated with aerobic exercise adaptation 
and to show the overall contribution of genetics to human 
performance. However, since these studies there have been 
few investigations to really extend this work by including higher 
powered studies via increasing participant number or by 
increasing the number of genetic variants studied. Indeed, the 
genotyping microarrays used in the above studies identify only 
common variants. Yet, 40 million DNA sequence variations have 
now been identified in the human genome (1000genomes.org). 
Further, based on the increasing number of personalised 
genomes, the number of variants a given individual carries are 
between 3-4 million, and rare variants carried by any one 
individuals ranges from 200,000 to 500,000 variants. There are 
therefore millions of common and rare SNPs between 
individuals that could contribute to exercise adaptation that have 
not yet been investigated. However, to identify genetic variants 
for a given trait it is clear that a large number of people and a 
large number of SNPs need to be investigated. Rare genetic 
variants associated with certain traits are extremely difficult to 
identify as it would be plausible to have to sequence the 
genome of a large number of people where that particular trait is 
identified, for example, in families.  
 
With whole genome sequencing becoming increasingly 
affordable then this approach could be the way to make 
progress within cellular and molecular exercise physiology. 
Despite the increasing affordability of genome sequencing, the 
costs of running adequately powered studies across large 
groups allowing comparison e.g. between elite and non-elite are 
still financially out of reach of most exercise science research 
institutes. Where more avenues for funding these types of 
studies are more widely available if the focus is human health 
related. Furthermore, in future these types of studies may also 
rely on employment of bioinformatician and computational 
facilities to analyze the DNA sequences to identify variations in 
DNA between individuals. Finally, there are ethical questions to 
consider when undertaking genome wide analysis for human 
performance traits or an individual’s ability to adapt to exercise, 
as it may provide information on increased disease risk or 
provide information that may be associated with negatively 
perceived connotations towards an individual’s genetic ability to 
perform well in certain performance measure or sports 
(Wackerhage et al., 2009). However, on the contrary 
understanding the different genetic variations between elite, 
non-elite and diseased individuals and their performance traits 
may enable important genetic variations to be identified that 
could lead to therapeutic strategies to improve muscular 
function in metabolic diseases such as type II diabetes, obesity 
or muscle loss with age. Therefore, studies conducted within 
this area of research within the sport, exercise and health 
sciences require more investment by research councils and 
charities.  
 
Satellite cells role in repair and regeneration of skeletal 
muscle tissue following exercise 
 
A fundamental discovery of the regenerative muscle ‘stem cell,’ 
or satellite cell by Mauro in 1961 (Mauro, 1961) initiated a 
growing research programme into the role of this fascinating cell 
type in muscle mass  maintenance and repair. Just over 40 
years later the first studies to investigate the role of the satellite 
cell in exercise adaptation emerged. Because adult human 
skeletal muscle fibres are terminally differentiated or post mitotic 
(i.e. a muscle fibres cannot replicate themselves due to being 
multinucleated structures), and fibre number is set in-utero, it is 
thought creation of new fibres or adequate repair cellular 
components of the fibres in adult skeletal muscle is not possible 
without a resident cell type that does have mitotic potential. The 
satellite cell was identified as having the capacity to proliferate, 
migrate and differentiate to enable cellular activation following 
damage, division (proliferation), movement to the site of injury 
(migration) and then fusion with the existing fibre to enable 
repair of the fibre (differentiation). In the early 1970s (around the 
same Era as Booth’s initial work in exercise biochemistry and 
gene expression), Schiaffino was undertaking pioneering work 
into characterizing the role of fibre type alterations via 
enzymatic/histochemical analysis following compensatory 
hypertrophy/synergistic ablation (reviewed in (Gutmann et al., 
1971). Importantly, around the same time, Schiaffino also began 
fundamental cellular work into the role of satellite cell during 
muscle regeneration and their ability to increase in number 
(Schiaffino et al., 1972), and fuse with existing muscle fibres 
after compensatory hypertrophy in order to repair damaged 
fibres (Schiaffino et al., 1976). Muscle stem cells were first 
isolated from muscle tissue to investigate the role of these cells 
in regeneration processes following tissue damage via the 
analysis of proliferation, migration and differentiation in-vitro in 
cells isolated from chicken muscle, with studies later 
progressing to cells isolated from human muscle (Cantini et al., 
1980; Sartore et al., 1979; Schiaffino et al., 1982). In 1992 
fascinating work by Rosenblatt and Parry, suggested that when 
satellite cells were lost through irradiation no increase in muscle 
mass is observed after compensatory hypertrophy, at this stage, 
suggesting these cells were fundamental in load induced 
muscle growth (Rosenblatt and Parry, 1992). Work in human 
muscle stem cells would later pave the work by Stewart and 
Rotwein to discover the role for ERK and AKT (also known as 
PKB) in regulating muscle stem cell proliferation, differentiation, 
survival (Foulstone et al., 2004; Lawlor et al., 2000). 
Subsequently, following the emergence of gene transfer by 
Booths lab (discussed above) together with early work by 
Stewart and Rotwein, these studies would go on to enable 
investigations into the overexpression of a hyperactive form of 
the Akt in 2002 that resulted in considerable skeletal muscle 
fibre hypertrophy (Pallafacchina et al., 2002). 
 
With respect to role for satellite cells in-vivo following exercise. It 
was demonstrated in 2001, using immuno-histological 
assessment and cross sectional analysis of sectioned and 
stained muscle tissue that, increased  muscle mass following 
resistance exercise was accompanied by increased myonuclear 
number (Kadi and Thornell, 2000). After these initial studies, 
investigators went on to suggest that the number of satellite 
cells (e.g. immune-histology of the satellite cell marker, Pax7) 
identified on muscle fibres increases and remains elevated in 
response to long term training where increased muscle mass 
was evident (Bruusgaard et al., 2010; Kadi and Thornell, 2000; 
Petrella et al., 2008). Further research by Smith and Merry 
(2012) exercised rats for 6 weeks using either resistance type or 
endurance type exercise, and found similar increases in satellite 
cell number in both modes of exercise (Smith and Merry, 2012). 
These data suggested that endurance and resistance training 
amplify the satellite cell pool to a similar extent. However, it was 
well known that resistance exercise led to increased mass with 
myonuclear addition (Bruusgaard et al., 2010; Kadi and 
Thornell, 2000; Petrella et al., 2008) whereas chronic endurance 
training does not usually increase muscle mass (Hoppeler et al., 
1985; Ingjer, 1979) or myonuclear number (Kurosaka et al., 
2012; Verney et al., 2008). At this time, this challenged the field 
to ask if satellite cells were actually required for resistance 
exercise-induced muscle growth or whether they were 
dispensable. Indeed, Type II fibres hypertrophy to a greater 
extent with resistance exercise vs. type I fibres, where it is also 
observed that there is an greater response from satellite cells in 
Type II fibres after exercise (Smith and Merry, 2012; Verdijk et 
al., 2009) supporting their requirement in load induced growth. 
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Furthermore, after the studies by Rosenblatt and Parry (1992), 
described above, that suggested if satellite cells were lost 
through irradiation no increase in muscle mass was observed, in 
2011, Peterson’s group and researcher McCarthy directly 
challenged this assumption. They genetically ablated Pax7 in 
skeletal muscle, essentially removing satellite cells while 
rodents underwent compensatory hypertrophy (McCarthy et al., 
2011). Fascinatingly, it was observed that muscle was still able 
to hypertrophy without satellite cells (McCarthy et al., 2011). 
Importantly however, this article did not address whether the 
lack of satellite cells would affect maintenance of the increase 
muscle size over longer periods. Where later it was established 
by Petersons’ group that following 8 weeks of load induced 
growth, hypertrophy is considerably reduced if satellite cells are 
absent (Fry et al., 2014). Furthermore, satellite cells have also 
been shown to be fundamental in hyperplasia and new fibre 
formation after synergistic ablation (Lepper et al., 2011). While 
new fibre formation does not occur in humans after experiencing 
physiologically relevant loads, hyperplasia does occur in rodents 
after supra-physiological load experienced post synergist 
ablation. Lepper and colleagues (2011) demonstrated that with 
genetic ablation of Pax7 (same model as McCarthy et al., 2011) 
new fibre formation was severely impaired suggesting an 
important role for satellite cells in regeneration after ablation-
induced muscle growth (Lepper et al., 2011). Finally, since 
these studies, it has more recently been confirmed that satellite 
cells are fundamental to the maintenance of functional muscle 
over time, where if satellite cells are lost the muscle tissue 
becomes more fibrotic and therefore less functional (Fry et al., 
2015; Lee et al., 2015). 
 
Future: A requirement for combined and integrative 
proteomic, epigenetic, gene regulatory, and genetic 
approaches in cellular and molecular physiology 
 
Finally, as we progress into the future, whilst cellular and 
molecular exercise physiology now uses some of the latest 
technology available to cellular and molecular biologists, a much 
more integrative approach is required. Given that proteins within 
cellular transduction networks are not only 
phosphorylated/dephosphorylated but also acetylated, 
deacetylated, sumoylayted, ubquitinated, glycosylated, 
methylated and demethylated (Consortium, 2012).  These other 
processes are currently understudied in relation to the 
abundance of studies that investigate phosphorylation and it 
role in controlling protein activity and cell signaling cascades 
following exercise. Other than small pockets of the community 
investigating acetylation/deacetylation such as deacetylation of 
PGC-1 alpha after exercise, as discussed above (Philp et al., 
2011), there are also few wider proteomic approaches being 
taken. Indeed, the first proteomic studies reporting training-
induced adaptations in rat (Burniston, 2008) and human skeletal 
muscle (Holloway et al., 2009) were only 7-8 years ago. Indeed, 
in 2009, approximately 2000 proteins from biopsy samples of 
human skeletal muscle were identified using mass 
spectrometry. The majority of those identified where abundant 
myofibrillar proteins, metabolic enzymes and kinases 
responsibly for phosphorylation (Parker et al., 2009). This is 
because, unlike RNA, it is difficult to isolate all proteins as they 
cannot be amplified like cDNA (product of mRNA following 
reverse transcription) via PCR, and the proteome is more 
diverse than the transcriptome, due to post translational 
modifications. This is particularly challenging when the 
identification of proteins following mass spectrometry are based 
on assessing the unique ‘masses’ of a skeletal muscle sample 
in comparison to masses that are predicted within existing gene 
and protein databases. Current proteomic technology is 
therefore somewhat behind transcriptomics. However, 
proteomics is likely to be even more powerful than, for example, 
western blotting going forward due to the reliance on the 
commercial availability of a suitable antibodies. Furthermore, 
proteins never before identified to play a role in exercise 
adaptation (e.g. PDIA3- Protein Disulfide Isomerase Family A 
Member 3 (Burniston et al., 2014)) are beginning to be 
discovered as regulators of aerobic capacity due to the latest 
‘mining’/profiling advancements within proteomics as opposed 
to undertaking western blotting for known kinases.  
 
Furthermore, following the necessary cell signaling response 
leading to transcription factor recruitment, the switching on/off of 
genes (gene expression) is an extremely complex process. 
Indeed, we now know that gene expression can be controlled 
epigenetically via modifications to DNA e.g. via methylation or 
histone modification (e.g. acetylation, deacetylation, 
ubiquitination, methylation) that allows altered chromatin access 
for transcription factor binding and promotion/suppression of 
gene expression. The epigenetic regulation of gene expression 
in exercise has only really been studied since 2009 onwards, as 
recently reviewed (Sharples et al., 2016). Most notably acute 
high-intensity cycling exercise evoked increased histone 
acetylation of Histone 3 in skeletal muscle, a process that is 
shown to be partly controlled by the removal of the histone 
deacetylases from the nucleus (McGee et al., 2009). Most 
notably the first studies to investigate DNA methylation and its 
control of gene expression in skeletal muscle following exercise 
was by Zierath’s group who showed reduced DNA methylation 
of PGC-1 alpha, mitochondrial transcription factor A (TFAM) and 
pyruvate dehydrogenase lipoamide kinase isozyme 4 (PDK4), 
all associated with mitochondrial biogenesis, immediately post 
an acute bout of high intensity aerobic exercise. These 
modifications correlated with reductions in the corresponding 
gene expression profiles (Barres et al., 2012). Taking this 
slightly further, it was later established that acute exercise 
reduced DNA methylation within the PGC-1 alpha promoter A, 
while methylation of lysine 4 on Histone 3 controlled expression 
within the PGC-1 alpha promoter B (Lochmann et al., 2015). 
Importantly, chronic exercise consisting of 6 months supervised 
aerobic exercise also altered the methylation of several genes 
associated with metabolism (Nitert et al., 2012). Finally, it has 
been known for a considerable period of time that skeletal 
muscle is somewhat programmable/has a memory, where, for 
example, early life nutrition in-utero can affect skeletal muscle 
metabolism and/or muscle size in later adult life in the offspring, 
and skeletal muscle cells seemingly remember the 
environmental niche from which there were derived once 
isolated in-vitro [(reviewed (Sharples et al., 2016)]. These 
interesting observations have been coupled with recent 
evidence to suggest that skeletal muscle cells in-vitro can retain 
altered DNA methylation profiles of key myogenic regulatory 
factors (myoD) if catabolic inflammatory stimuli are encountered 
early in their proliferative lifespan; an observation that 
corresponds with an increased susceptibly to a later proliferative 
encounter with the same catabolic inflammation stimulus. This 
work is suggestive of an epigenetic mechanism underlying 
programmable skeletal muscle cells/skeletal muscle cell 
memory (Sharples et al., 2015). A so called epi-memory 
(Sharples et al., 2016) and its role in exercise adaptation is of 
considerable interest to cellular and molecular exercise 
physiologists with potential to enable the understanding for the 
role of previous exercise encounters, both acute and chronic, on 
the ability of skeletal muscle to respond to future exercise. This 
could enable better periodization of exercise bouts and recovery 
from injury. However, there are few human exercise studies to 
investigate the role of epigenetics in controlling the gene 
regulatory networks in adaptation to training, detraining or 
retraining, especially in response to skeletal muscle hypertrophy 
following resistance exercise. A recent study investigated gene 
expression profiles (via RNA sequencing, profiling 
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approximately 36,000 transcripts) in response to endurance 
exercise training, detraining and retraining and found no 
difference in the gene expression profile in response post 
training or retraining (following 9 months of detraining). 
However, 9 months is a considerable period of time i.e. a whole 
competitive season, and there were altered transcriptional 
profiles after repeated bouts of exercise with no epigenetic 
analysis performed (Lindholm et al., 2016). Therefore, these 
types of studies in endurance exercise and resistance exercise 
warrant future investigation with respect to the role of 
epigenetics in the control of gene expression following exercise.   
 
Finally, there are also several post transcriptional modifications 
to mRNA that can lead to altered protein structure and function. 
This can occur via small RNA species known as siRNA (small 
interfering RNA) and miRNA’s (micro RNA) (Valencia-Sanchez 
et al., 2006). Investigations have been conducted in response to 
both aerobic exercise and resistance exercise and miRNA 
profiles (McCarthy and Esser, 2007; Safdar et al., 2009) and 
miRNA expression can differ between high and low responders 
to exercise adaptation (Davidsen et al., 2011). Work by 
Timmons’ group was really the most comprehensive in this 
area, as genetic, gene expression and miRNA profiles were 
undertaken within the same study. Indeed, they found that a 
gene network associated with the transcription factors Runx1, 
Pax3 and Sox9 were associated with adaptation to endurance 
exercise and that the regulatory miRNA’s post-transcriptionally 
regulated these transcription factors (Keller et al., 2011). 
However, there are few studies that investigate the role that the 
miRNA’s have on the transcribed mRNA sequences and 
therefore the protein structure and function of the 
correspondingly translated proteins in response to exercise.  
 
Overall, in the future more extensive investigations using current 
epigenetic and proteomic analysis in combination with gene 
expression microarray/RNA sequencing and genetic profiling 
using the latest technological advancements are required in 
exercising knock-out, overexpression and compensatory 
hypertrophy rodent models, as well as human exercise 
intervention studies. This will enable the field to delve into the 
deepest regulatory networks and take cellular and molecular 
exercise physiology into the next generation of research to 
uncover the mechanistic underpinnings of exercise adaptation.  
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